Financhill
Sell
37

SHC Quote, Financials, Valuation and Earnings

Last price:
$11.32
Seasonality move :
9.23%
Day range:
$11.12 - $11.38
52-week range:
$9.53 - $17.08
Dividend yield:
0%
P/E ratio:
142.00x
P/S ratio:
2.92x
P/B ratio:
7.79x
Volume:
1.1M
Avg. volume:
1.3M
1-year change:
-3.97%
Market cap:
$3.2B
Revenue:
$1.1B
EPS (TTM):
$0.08

Analysts' Opinion

  • Consensus Rating
    Sotera Health has received a consensus rating of Leans Bullish. The company's average rating is a Leans Bullish based on 3 Buy ratings, 3 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $14.50, Sotera Health has an estimated upside of 27.64% from its current price of $11.36.
  • Price Target Downside
    According to analysts, the lowest downside price target is $13.00 representing -14.44% downside risk from its current price of $11.36.

Fair Value

  • According to the consensus of 6 analysts, Sotera Health has 27.64% upside to fair value with a price target of $14.50 per share.

SHC vs. S&P 500

  • Over the past 5 trading days, Sotera Health has overperformed the S&P 500 by 0.91% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Sotera Health does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Sotera Health has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Sotera Health reported revenues of $254.5M.

Earnings Growth

  • Sotera Health earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Sotera Health reported earnings per share of -$0.05.
Enterprise value:
5.1B
EV / Invested capital:
1.95x
Price / LTM sales:
2.92x
EV / EBIT:
20.41x
EV / Revenue:
4.64x
PEG ratio (5yr expected):
--
EV / Free cash flow:
48.55x
Price / Operating cash flow:
30.56x
Enterprise value / EBITDA:
12.36x
Gross Profit (TTM):
$610.6M
Return On Assets:
0.8%
Net Income Margin (TTM):
2.24%
Return On Equity:
5.79%
Return On Invested Capital:
0.94%
Operating Margin:
22.41%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-03-31 2024-03-31 2025-03-31 2024-03-31 2025-03-31
Income Statement
Revenue $987.5M $1.1B $1.1B $248.2M $254.5M
Gross Profit $539.6M $592.8M $610.6M $127.1M $135.4M
Operating Income $228.2M $296.5M $301.5M $53.2M $57M
EBITDA -$35.3M $426.2M $415.8M $93.2M $66.9M
Diluted EPS -$0.93 $0.19 $0.08 $0.02 -$0.05
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Balance Sheet
Current Assets $328.4M $371.6M $923.8M $487.2M $555M
Total Assets $2.8B $2.8B $3.4B $3.1B $3.1B
Current Liabilities $138M $143.9M $600.1M $152.3M $226M
Total Liabilities $2.3B $2.2B $3.1B $2.6B $2.7B
Total Equity $465.7M $642.1M $361.1M $429.4M $414.1M
Total Debt $1.8B $1.7B $2.2B $2.2B $2.2B
Trailing 12 Months Fiscal Quarters
Period Ending 2023-03-31 2024-03-31 2025-03-31 2024-03-31 2025-03-31
Cash Flow Statement
Cash Flow Operations $261.9M -$171.9M $270M $9.7M $55.5M
Cash From Investing -$191.4M -$204.8M -$164M -$34.9M -$19.9M
Cash From Financing $472.1M -$19.9M -$46.7M -$11.9M -$8.1M
Free Cash Flow $70M -$376.8M $105.9M -$25.2M $35.6M
SHC
Sector
Market Cap
$3.2B
$33.7M
Price % of 52-Week High
66.51%
47.34%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.79%
1-Year Price Total Return
-3.97%
-35.46%
Beta (5-Year)
--
0.632
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Buy
Level $11.18
200-day SMA
Sell
Level $13.38
Bollinger Bands (100)
Sell
Level 11.07 - 13.13
Chaikin Money Flow
Sell
Level -73.7M
20-day SMA
Sell
Level $11.76
Relative Strength Index (RSI14)
Sell
Level 42.79
ADX Line
Sell
Level 23.46
Williams %R
Neutral
Level -68.3473
50-day SMA
Sell
Level $11.94
MACD (12, 26)
Sell
Level -0.29
25-day Aroon Oscillator
Sell
Level -72
On Balance Volume
Sell
Level -18.6M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (1.3829)
Sell
CA Score (Annual)
Level (-1.5887)
Buy
Beneish M-Score (Annual)
Level (-2.8068)
Buy
Momentum Score
Level (6)
Sell
Ohlson Score
Level (2.1557)
Buy
Piotroski F Score (Annual)
Level (7)
Sell
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (6)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three segments: Sterigenics, Nordion, and Nelson Labs. Sterigenics provides outsourced terminal sterilization and irradiation services for medical device, pharmaceutical, food safety, and applications; Nordion provides Co-60 and gamma irradiators, which are the key components to the gamma sterilization process; and Nelson Labs provides outsourced microbiological and analytical chemistry testing for the medical device and pharmaceutical industries. Its geographical segments are the United States, Canada, Europe and other regions.

Stock Forecast FAQ

In the current month, SHC has received 3 Buy ratings 3 Hold ratings, and 0 Sell ratings. The SHC average analyst price target in the past 3 months is $14.50.

  • Where Will Sotera Health Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Sotera Health share price will rise to $14.50 per share over the next 12 months.

  • What Do Analysts Say About Sotera Health?

    Analysts are divided on their view about Sotera Health share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Sotera Health is a Sell and believe this share price will drop from its current level to $13.00.

  • What Is Sotera Health's Price Target?

    The price target for Sotera Health over the next 1-year time period is forecast to be $14.50 according to 6 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.

  • Is SHC A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Sotera Health is a Leans Bullish. 3 of 6 analysts rate the stock a Leans Bullish at this time.

  • How Can I Buy Shares Of SHC?

    You can purchase shares of Sotera Health via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Sotera Health shares.

  • What Is The Sotera Health Share Price Today?

    Sotera Health was last trading at $11.32 per share. This represents the most recent stock quote for Sotera Health. Yesterday, Sotera Health closed at $11.36 per share.

  • How To Buy Sotera Health Stock Online?

    In order to purchase Sotera Health stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Is Planet Labs Stock Up Today?
Why Is Planet Labs Stock Up Today?

Planet Labs (NYSE: PL) opened Friday trading with an unmistakable…

Is Coherent Stock Breaking Out?
Is Coherent Stock Breaking Out?

Coherent (NYSE: COHR) has spent the better part of two years…

What Is The Long-term Outlook for AMC Stock?
What Is The Long-term Outlook for AMC Stock?

Meme stock extraordinaire AMC Entertainment Holdings, Inc. (NYSE:AMC) has long…

Stock Ideas

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 53x

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 42x

Sell
43
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Buy
95
AVAV alert for Jun 27

AeroVironment [AVAV] is up 2.13% over the past day.

Buy
70
AEVA alert for Jun 27

Aeva Technologies [AEVA] is up 8.52% over the past day.

Buy
88
TSSI alert for Jun 27

TSS [TSSI] is down 2.73% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock